A phase 2 study of HLX07 as monotherapy or combination therapy in patients with locally advanced, unresectable, or metastatic esophageal squamous cell carcinoma

被引：0
|
作者：
Huang, Jing
Liu, Yun
Wu, Tao
Liu, Zhen-Yang
Zhou, Jin
Yuan, Yuan
Yang, Mudan
Liu, Bo
Tan, Zhenbo
Zhuang, Wu
Chen, Jiayan
Liu, Yanqing
Yu, Haoyu
Wang, Qingyu
Zhu, Jun
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Natl Clin Res Ctr Canc, Canc Hosp, Beijing, Peoples R China
[2] Anyang Tumor Hosp, Anyang, Peoples R China
[3] Cent South Univ, Xiangya Sch Med, Hunan Canc Hosp, Affiliated Canc Hosp, Changsha, Peoples R China
[4] Univ Elect Sci & Technol China, Sichuan Canc Hosp & Inst, Sichuan Canc Ctr, Canc Hosp,Sch Med, Chengdu, Peoples R China
[5] Xuzhou Cent Hosp, Xuzhou, Jiangsu, Peoples R China
[6] Shanxi Canc Hosp, Taiyuan, Peoples R China
[7] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Jinan, Peoples R China
[8] Xingtai Peoples Hosp, Xingtai, Peoples R China
[9] Fujian Canc Hosp, Fuzhou, Peoples R China
[10] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
[11] Shanghai Henlius Biotech Inc, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4029
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of HLX07 monotherapy in advanced cutaneous squamous cell carcinoma: An open-label, multicentre phase II study
    Li, C.
    Zhu, D.
    Fan, Z.
    Chen, Y.
    Chen, Y.
    Li, Y.
    Ji, M.
    Duan, P.
    Su, J.
    Yang, J.
    Tang, Y.
    Zhang, M.
    Wang, S.
    Yu, G.
    Huang, Y.
    Chen, R.
    Hu, X.
    Wang, L.
    Wang, Q.
    Zhu, J.
    ANNALS OF ONCOLOGY, 2023, 34 : S1500 - S1500
  • [2] Nivolumab combination therapy as first-line treatments for unresectable, advanced or metastatic esophageal squamous cell carcinoma
    Rogers, Jane E.
    Yamashita, Kohei
    Sewastjanow-Silva, Matheus
    Rosa Vicentini, Ernesto
    Waters, Rebecca
    Ajani, Jaffer A.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2023, 23 (06) : 565 - 571
  • [3] Photodynamic Therapy for Local Failure After Chemoradiotherapy for Patients With Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma
    Nagahisa, Emiko
    Yano, Tomonori
    Minashi, Keiko
    Kojima, Takashi
    Kaneko, Kazuhiro
    Ohtsu, Atsushi
    Oono, Yasuhiro
    Ikematsu, Hiroaki
    GASTROINTESTINAL ENDOSCOPY, 2010, 71 (05) : AB237 - AB237
  • [4] Nimotuzumab Combined With Concurrent Chemoradiation Therapy in Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma
    Zhai, Y. R.
    Hui, Z.
    Wang, X.
    Liang, J.
    Wang, W.
    Feng, Q.
    Zhou, Z.
    Wang, X.
    Xiao, Z.
    Bi, N.
    Wang, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E205 - E205
  • [5] Nivolumab in unresectable advanced, recurrent or metastatic esophageal squamous cell carcinoma
    Ikeda, Go
    Miyakoshi, Jun
    Yamamoto, Shun
    Kato, Ken
    FUTURE ONCOLOGY, 2024, 20 (11) : 665 - 677
  • [6] A phase II trial of dacomitinib in locally advanced unresectable or metastatic skin squamous cell carcinoma
    Bossi, P.
    Cavalieri, S.
    Perrone, F.
    Miceli, R.
    Ascierto, P.
    Locati, L.
    Bergamini, C.
    Granata, R.
    Alfieri, S.
    Resteghini, C.
    Galbiati, D.
    Busico, A.
    Paielli, N.
    Patuzzo, R.
    Maurichi, A.
    Gallino, G.
    Ruggeri, R.
    Mariani, L.
    Palla, M.
    Licitra, L.
    ANNALS OF ONCOLOGY, 2017, 28 : 68 - 68
  • [7] A multicenter phase II study of atezolizumab monotherapy following definitive chemoradiotherapy for unresectable locally advanced esophageal squamous cell carcinoma (EPOC1802)
    Bando, H.
    Kumagai, S.
    Kotani, D.
    Saori, M.
    Habu, T.
    Tsushima, T.
    Hara, H.
    Kadowaki, S.
    Kato, K.
    Chin, K.
    Yamaguchi, K.
    Kageyama, S-I.
    Hojo, H.
    Nakamura, M.
    Tachibana, H.
    Wakabayashi, M.
    Fukutani, M.
    Fuse, N.
    Nishikawa, H.
    Kojima, T.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1102 - S1103
  • [8] Efficacy and safety of definitive chemoradiotherapy in patients with unresectable locally advanced esophageal squamous cell carcinoma
    Habu, Takumi
    Bando, Hideaki
    Kumanishi, Ryosuke
    Ogata, Takatsugu
    Fujisawa, Takeshi
    Kumagai, Shogo
    Fujiwara, Hisashi
    Mishima, Saori
    Kotani, Daisuke
    Nakamura, Masaki
    Hojo, Hidehiro
    Yoda, Yusuke
    Koyama, Shohei
    Nishikawa, Hiroyoshi
    Yano, Tomonori
    Fujita, Takeo
    Kadowaki, Shigenori
    Muro, Kei
    Kinoshita, Takahiro
    Kojima, Takashi
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [9] A prospective study of camrelizumab monotherapy following definitive concurrent chemoradiotherapy in patients with unresectable locally advanced esophageal squamous cell cancer
    Wang, J.
    Cheng, Y.
    Wu, Y.
    Cao, F.
    Liu, Q.
    Gao, G.
    ANNALS OF ONCOLOGY, 2021, 32 : S838 - S838
  • [10] Combined nimotuzumab with chemoradiotherapy in patients with locally advanced or metastatic esophageal squamous cell carcinoma: A retrospective study
    Lai, Xiaojing
    Gu, Qing
    Zheng, Xiao
    Liu, Guan
    Feng, Wei
    Lin, Xiao
    Mao, Weimin
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2016, 12 (05) : 89 - 95
12345